{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:37:36Z","timestamp":1792424256661,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:00:00Z","timestamp":1757203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U54 CA274375"],"award-info":[{"award-number":["U54 CA274375"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA198887"],"award-info":[{"award-number":["R01 CA198887"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tranon.2025.102528","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:47:30Z","timestamp":1757519250000},"page":"102528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and analytical validation of a multiplex diagnostic qPCR-array as a potential application in predicting the response to neoadjuvant chemotherapy in muscle invasive bladder cancer"],"prefix":"10.1016","volume":"61","author":[{"given":"Toru","family":"Sakatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5185-2869","authenticated-orcid":false,"given":"Sunao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-8233","authenticated-orcid":false,"given":"Owen T.M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-4906","authenticated-orcid":false,"given":"Catherine","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Luthringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hogrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-8662","authenticated-orcid":false,"given":"Hideki","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102528_bib0001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tranon.2025.102528_bib0002","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2025.102528_bib0003","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.tranon.2025.102528_bib0004","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(99)02292-8","article-title":"Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2025.102528_bib0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.tranon.2025.102528_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JU.0000000000003981","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; Amended 2020, 2024)","volume":"212","author":"Holzbeierlein","year":"2024","journal-title":"J. Urol."},{"key":"10.1016\/j.tranon.2025.102528_bib0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Advanced bladder cancer meta-analysis C: neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tranon.2025.102528_bib0008","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-14-0029","article-title":"External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort","volume":"23","author":"Chen","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.tranon.2025.102528_bib0009","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13000-014-0200-1","article-title":"Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature","volume":"9","author":"Zhang","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.tranon.2025.102528_bib0010","article-title":"A diagnostic gene expression signature for bladder cancer can stratify cases into prescribed molecular subtypes and predict outcome","volume":"12","author":"Chen","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.tranon.2025.102528_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104236","article-title":"Predictors of response to neoadjuvant therapy in urothelial cancer","volume":"194","author":"Tripathi","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tranon.2025.102528_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173056","article-title":"Contemporary molecular markers for predicting systemic treatment response in urothelial bladder cancer: a narrative review","volume":"16","author":"Dimitrov","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2025.102528_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.11.017","article-title":"Biodynamic prediction of neoadjuvant chemotherapy response: results from a prospective multicenter study of predictive accuracy among muscle-invasive bladder cancer patients","volume":"41","author":"Laviana","year":"2023","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.tranon.2025.102528_bib0014","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.18632\/oncotarget.28302","article-title":"Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer","volume":"13","author":"Murphy","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2025.102528_bib0015","series-title":"(CLSI) CaLSI: Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods; Approved Guideline","year":"2005"},{"key":"10.1016\/j.tranon.2025.102528_bib0016","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tranon.2025.102528_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9837310","article-title":"RNA sequencing of formalin-fixed, paraffin-embedded specimens for gene expression quantification and data mining","volume":"2016","author":"Guo","year":"2016","journal-title":"Int. J. Genomics"},{"key":"10.1016\/j.tranon.2025.102528_bib0018","unstructured":"CAP guidelines."},{"key":"10.1016\/j.tranon.2025.102528_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194901","article-title":"Influence of neoadjuvant chemotherapy on survival outcomes of radical cystectomy in pathologically proven positive and negative lymph nodes","volume":"15","author":"Kaczmarek","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2025.102528_bib0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmoldx.2019.01.009","article-title":"Analytical validation of variants to aid in genotype-guided therapy for oncology","volume":"21","author":"Swart","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.tranon.2025.102528_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1069059","article-title":"Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ","volume":"13","author":"Dabbs","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2025.102528_bib0022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2217\/14622416.8.4.353","article-title":"Analytical validation of genotyping assays in the biomarker laboratory","volume":"8","author":"Isler","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.tranon.2025.102528_bib0023","article-title":"Analytical validation of MyProstateScore 2.0","volume":"15","author":"Meyers","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.tranon.2025.102528_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jmoldx.2017.10.001","article-title":"Analytical validation of a next-generation sequencing assay to monitor immune responses in solid tumors","volume":"20","author":"Conroy","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.tranon.2025.102528_bib0025","article-title":"Modified Glasgow prognostic score as a predictor of recurrence in patients with high grade non-muscle invasive bladder cancer undergoing intravesical Bacillus Calmette-Guerin immunotherapy","volume":"12","author":"Ferro","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.tranon.2025.102528_bib0026","article-title":"A comparative study of the triglycerides\/HDL ratio and pseudocholinesterase levels in patients with bladder cancer","volume":"12","author":"Crocetto","year":"2022","journal-title":"Diagnostics (Basel)"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:50:31Z","timestamp":1772895031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325002591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"alternative-id":["S1936523325002591"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102528","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and analytical validation of a multiplex diagnostic qPCR-array as a potential application in predicting the response to neoadjuvant chemotherapy in muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102528"}}